Online Consultation For Device Closure of ASD (Amplatzer Septal Occluder) Doctors in Turkey

Yes. Turkey hospitals are well-equipped with advanced interventional cardiology infrastructure for percutaneous ASD (Atrial Septal Defect) closure using the Amplatzer Septal Occluder. These minimally invasive, catheter-based procedures are performed in high-tech cardiac catheterisation labs with real-time fluoroscopy and 3D echocardiographic imaging (TEE, ICE) and multidisciplinary heart teams, including interventional cardiologists and echocardiographers.

MediGence partners with many of these hospitals, offering verified cardiologists and streamlined access to ASD device closure packages for both adult and paediatric patients.

Percutaneous ASD closure using an Amplatzer device is indicated in patients with:

• Secundum-type atrial septal defects (most suitable type for device closure)
• Left-to-right shunt with right heart enlargement
• Paradoxical embolism or stroke
• Exercise intolerance, arrhythmias, or pulmonary overcirculation
• Cryptogenic stroke with patent foramen ovale

Device closure is typically done in patients who are asymptomatic but at risk of long-term complications or have symptoms such as fatigue, palpitations, or shortness of breath.

Yes. For suitable candidates, ASD device closure using the Amplatzer Septal Occluder offers a complete and permanent solution. It eliminates abnormal blood flow between the atria and reduces the risks of:

• Heart failure or pulmonary hypertension
• Atrial arrhythmias
• Stroke due to embolism
• Right heart dilation and dysfunction

Recovery is quick, with most patients discharged within 24–48 hours. Lifelong monitoring is recommended, but most resumes are completed in a few weeks.

Yes, Turkey is a preferred destination for advanced heart care, including Amplatzer ASD device closures, for international patients seeking specialised treatment. Benefits include access to internationally trained cardiologists and hybrid cath labs, fast-track diagnostic workup and same-day interventions, concierge support for travel, medical visas, and translation, child and adult ASD closure expertise under one roof, and personalised care pathways and follow-up arrangements.

MediGence offers pre-negotiated packages and helps coordinate comprehensive care journeys, from consultation to device closure and post-operative support.

Yes. Turkey-based cardiologists offer teleconsultation services via MediGence to:

• Review echocardiograms, MRI/CT scans, or cardiac catheterisation reports
• Determine device closure eligibility and discuss risks/benefits
• Explain the closure procedure and device type
• Provide treatment plans, cost estimates, and expected outcomes
• Assist with medical travel and scheduling hospital admission

Virtual consultations ensure timely and informed decision-making, especially for overseas patients seeking elective or second-opinion procedures.

Turkish cardiologists who close Atrial Septal Defect (ASD) devices are typically specialists in adult congenital heart disease or interventional pediatric cardiologists. They complete a medical degree, a residency in internal medicine or pediatrics, and a fellowship in cardiology. They are skilled in post-procedure care, device placement, and selection. MediGence carefully vets all listed specialists, ensuring that only qualified and experienced interventional cardiologists are recommended for ASD device closure.

The Turkish Medical Council website, which lists certified specialists by field, is a good starting point for verifying a cardiologist's legitimacy for ASD closure. Prominent hospitals frequently have comprehensive profiles that include years of experience and procedural expertise. Check for international training credentials or affiliations with reputable cardiac institutions. Becoming a member of the Turkish Society of Cardiology or the Pediatric Cardiology Society increases trust.

MediGence ensures transparency by listing only pre-screened, highly experienced physicians and facilities.

The Amplatzer Septal Occluder is one of the most widely used and clinically tested devices for ASD closure, offering:

• Excellent long-term closure rates (>95%)
• Low risk of embolisation or device-related complications
• Minimally invasive approach without open-heart surgery
• Rapid patient recovery and early discharge
• Suitability for both children and adults

The device is self-expanding, made from nitinol wire mesh, and placed securely across the septal defect under imaging guidance.

Post-closure care in Turkey includes:

• Monitoring in a cardiac step-down or day-care unit for 12–24 hours
• Follow-up echocardiograms at 1, 6, and 12 months
• Restrictions on strenuous activity for 1–2 weeks
• Guidance on infective endocarditis prophylaxis during dental or surgical procedures

MediGence helps patients book their follow-up visits, track medication adherence, and access international second opinions if needed.